Andrew Plump Insider Profile

4 Followers
Andrew Plump, Research & Development Director at Takeda Pharmaceutical Co, holds ― shares in Takeda Pharmaceutical Co (Ticker: TKPHF).
Andrew  Plump

Andrew Plump
Takeda Pharmaceutical Co (TKPHF)
Research & Development Director

Not Ranked
Andrew Plump has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Andrew Plump does not currently own shares as a corporate insider.
A breakdown of Andrew Plump's holdings

Insider Roles

Takeda Pharmaceutical Co
(TKPHF)
Research & Development Director
Roles that Andrew Plump holds in companies

Most Profitable Insider Trade

Stock:
Takeda Pharmaceutical Co
(TKPHF)
Rating:Informative Sell
Date:Jul 12, 2022 - Today
Return:-13.60%
The most profitable trade made by Andrew Plump

Andrew Plump's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Takeda Pharmaceutical Co
Jul 12, 2022
Research & Development Director
Uninformative Buy
Success Rate for TKPHF
0 out of 1 profitable transactions on TKPHF
0%
Average Return for TKPHF
Average return per transaction on TKPHF
-13.60%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 12, 2022
Uninformative Buy
$0.00
-
$0.00
Jul 12, 2022
Informative Sell
$417.50K
-
$14.40
-13.60%
List of latest transactions for each holding click on a transaction to see Andrew Plump's performance on stock

Andrew Plump insider profile FAQ

What is the percentage of profitable transactions made by Andrew Plump?
The percentage of profitable transactions made by Andrew Plump is ―.
    What is the average return per transaction made by Andrew Plump?
    The average return per transaction made by Andrew Plump is ―.
      What stocks does Andrew Plump hold?
      Andrew Plump holds: TKPHF stocks.
        What was Andrew Plump’s latest transaction?
        Andrew Plump latest transaction was an Uninformative Buy of ―.
          What was Andrew Plump's most profitable transaction?
          Andrew Plump’s most profitable transaction was an Informative Sell of TKPHF stock on July 12, 2022. The return on the trade was -13.60%.
            What is Andrew Plump's role in Takeda Pharmaceutical Co?
            Andrew Plump's role in Takeda Pharmaceutical Co is Research & Development Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.